Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 7Head & Neck 4Gastrointestinal 4Thoracic 3Sarcoma 3Genitourinary 3Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1Lymphoid 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Mesothelioma, Malignant 1

Interventions

Carboplatin 191pembrolizumab 155Pemetrexed 134Cisplatin 117durvalumab 71Paclitaxel 71osimertinib 67Nivolumab 66Docetaxel 63Specimen Handling 61atezolizumab 57Magnetic Resonance Spectroscopy 50Etoposide 46Gemcitabine 42Radiotherapy 39Radiosurgery 37130-nm albumin-bound paclitaxel 34Drug Therapy 30Cetuximab 28Bevacizumab 27Ipilimumab 25Taxes 23cemiplimab 22tislelizumab 20Platinum 20amivantamab 18Radiation 18Immunoglobulin G 171,2-diaminocyclohexaneplatinum II citrate 17Disulfides 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Proton Therapy × Thoracic × 90 days × Clear all
NCT01993810 2026-05-27

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
330 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02444741 2026-05-15

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
124 enrolled 15 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05655078 2026-03-30

HIT-Meso

University College, London

Phase NA Recruiting
148 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡